Literature DB >> 11426627

The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood.

H M Kempski1, N T Sturt.   

Abstract

The TEL-AML1 fusion which results from the t(12;21) rearrangement in childhood B-precursor acute lymphoblastic leukaemia (B-precursor ALL) is often accompanied by loss of the untranslocated TEL allele. From 32/109 children with B-precursor ALL screened for these abnormalities, we found evidence for del 12p, including the loss of the untranslocated TEL allele, to be the secondary event to take place in the leukaemic cells from those patients positive for these abnormalities. This suggests that the initial or predisposing event is the generation of a TEL-AML1 fusion, followed by the promoting event of a deletion of a gene(s) on 12p. A striking characteristic of the leukaemic cells in 61% of the patients showing t(12:21). was the substantial evolution of the primary clonal line containing the reciprocal TEL-AML1 fusion. We were able to show loss of normal TEL in the same patients by interphase fluorescence in situ hybridisation (FISH) analysis and reverse-transcriptase polymerase chain reaction (RT-PCR).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11426627     DOI: 10.3109/10428190009054879

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.

Authors:  Hee Yeon Woo; Dae Won Kim; Hyosoon Park; Ki Woong Seong; Hong Hoe Koo; Sun Hee Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

2.  Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.

Authors:  Yanliang Jin; Xingwei Wang; Shaoyan Hu; Jingyan Tang; Benshang Li; Yihuan Chai
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452

3.  ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Abir Gmidène; Hatem Elghezal; Hlima Sennana; Yosra Ben Youssef; Balkiss Meddeb; Moez Elloumi; Abderrahim Khlif; Ali Saad
Journal:  Adv Hematol       Date:  2009-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.